LadRx Corporation (LADX)
OTCMKTS
· Delayed Price · Currency is USD
0.1100
-0.0900 (-45.00%)
At close: Dec 5, 2025
LadRx Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
54.46K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
LadRx News
- 9 months ago - LadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13th - GlobeNewsWire
- 1 year ago - LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates - Business Wire
- 2 years ago - LadRx Issues 2024 Update to Shareholders - Business Wire